T
he New Haven area has become a hub for thriving and growing young bioscience companies like Arvinas and Cybrexa Therapeutics, which are working to develop potentially game-changing cancer cures.
The region’s biotechs are developing treatments for a range of ailments, from Alzheimer’s disease to spinal-cord injuries.
But just as a growing infant can’t stay in an incubator for long, many New Haven-born bioscience companies need room to grow — and fast.
Image: PHOTO | NEW HAVEN BIZ - John Keogh, senior broke with Colliers International, in lab space at 5 Science Park on Winchester Avenue in New Haven.
